SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,059.37 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 646.69 |
| Book Value / Share | 2.87 |
| Price / Book | n/a |
| NCAV ($M) | 373.52 |
| NCAV / Share | 1.66 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.26 |
| Return on Assets (ROA) | 0.26 |
| Return on Equity (ROE) | 0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.64 |
| Current Ratio | 7.65 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 469.10 |
| Assets | 742.27 |
| Liabilities | 95.58 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 535.18 |
| Operating Income | 209.78 |
| Net Income | 162.19 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 101.85 |
| Cash from Investing | -18.44 |
| Cash from Financing | -5.11 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 104,467 | 573,052 | 18.23 | |
| 186,647 | 924,712 | 20.18 | |
| 73,857 | 809,308 | 9.13 | |
| 156,736 | 1,109,684 | 14.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRSP – CRISPR Therapeutics AG | CRVS – Corvus Pharmaceuticals, Inc. |
| CURR – CURRENC Group Inc. | EOLS – Evolus, Inc. |
| ESPR – Esperion Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io